or Try an Advanced Search...

    Cognitive Disorders Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. 0.51
    CGTX D Cognition Therapeutics, Inc. 0.00
    ANVS D Annovis Bio, Inc. 2.13
    ARCT F Arcturus Therapeutics Ltd. -1.29
    OMER F Omeros Corporation -4.98
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Alzheimer's Disease Disorders Medicine Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Cognitive Impairment Dementia Early Stage Alzheimer's Disease Learning Disabilities Neurodegeneration Schizophrenia Addiction Adhd Amphetamine Amyloid Arthroscopy Autism Autism Spectrum Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Cognitive Disorders stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 5.23
    XPH D SPDR S&P Pharmaceuticals ETF 4.74
    PSIL F AdvisorShares Psychedelics ETF 4.32
    FBT D First Trust Amex Biotech Index Fund 4.22
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 3.73
    View all Cognitive Disorders ETFs...
    Compare ETFs
    Compare IBRN to PSIL Compare XPH to PILL Compare XPH to PSIL

        Cognitive Disorders Stocks Recent News

        Date Stock Title
        Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
        Apr 19 ANVS Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
        Apr 19 ANVS Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
        Apr 18 CGTX Cognition Therapeutics: Approaching Phase 2 Readout In Alzheimer's
        Apr 18 ANVS DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
        Apr 18 ITCI Intra-Cellular Therapies drops 2%, prices $500M equity financing
        Apr 18 ITCI Intra-Cellular Therapies Prices Public Offering of Common Stock
        Apr 17 ITCI Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point
        Apr 17 ANVS Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
        Apr 17 ITCI Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
        Apr 17 ITCI Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
        Apr 17 ITCI Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
        Apr 16 ITCI Intra-Cellular Therapies announces proposed public offering of common stock
        Apr 16 ITCI Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
        Apr 16 ITCI Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
        Apr 16 ARCT As more rare disease therapies launch, their prices are rising
        Apr 16 ANVS Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
        Apr 16 ITCI UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
        Apr 16 ANVS Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
        Apr 16 ITCI Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Alzheimer's Disease Disorders Medicine Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Cognitive Impairment Dementia Early Stage Alzheimer's Disease Learning Disabilities Neurodegeneration Schizophrenia Addiction Adhd Amphetamine Amyloid Arthroscopy Autism Autism Spectrum Disorder
        Cognitive Disorders

        Cognitive Disorders are a group of mental health conditions that affect a person's ability to think, remember, and learn. These disorders can range from mild to severe and can include conditions such as dementia, Alzheimer's disease, and traumatic brain injury. Symptoms of cognitive disorders can include difficulty with memory, concentration, problem-solving, and decision-making. Treatment for cognitive disorders typically involves a combination of medication, therapy, and lifestyle changes.

        Browse All Tags